Even though Bacille Calmette-Guerin (BCG) is contraindicated in patients with HIV infection, it still may be given to small children in developing countries with a high rate of tuberculosis. A vaccinated child may develop an immune reconstitution inflammatory syndrome (IRIS) following the initiation of highly active antiretroviral therapy (HAART).